# Jian Ding

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jian-ding/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,546 |
| Field | Cancer therapeutics and mechanisms |
| h-index | 64 |
| i10-index | 355 |
| Last Known Institution | Nanchang University |
| OpenAlex ID | https://openalex.org/A5089348951 |
| ORCID iD | https://orcid.org/0000-0002-5815-4956 |
| Works | 566 |

## Researcher papers

- [Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors](https://scholariq.org/papers/targeting-epigenetic-crosstalk-as-a-therapeutic-strategy-for-ezh2-aberrant-solid/)
- [A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia](https://scholariq.org/papers/a-36-week-multicenter-randomized-double-blind-placebo-controlled-parallel-group/)

## Researcher topics

- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Bioactive Compounds and Antitumor Agents](https://scholariq.org/topics/bioactive-compounds-and-antitumor-agents/)

## Researcher university

- [Nanchang University](https://scholariq.org/institutions/nanchang-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.